Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment

Recent clinical evidence revealed that the use of beta-blockers such as propranolol, prior to diagnosis or concurrently with chemotherapy, could increase relapse-free and overall survival in breast cancer patients. We therefore hypothesized that propranolol may be able to increase the efficacy of ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasquier, Eddy, Ciccolini, Joseph, Carre, Manon, Giacometti, Sarah, Fanciullino, Raphaelle, Pouchy, Charlotte, Montero, Marie-Pierre, Serdjebi, Cindy, Kavallaris, Maria, André, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2011
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248157/
https://www.ncbi.nlm.nih.gov/pubmed/22006582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248157/
https://www.ncbi.nlm.nih.gov/pubmed/22006582

Ejemplares similares